Algert Global’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-34,166
Closed -$230K 1430
2022
Q1
$230K Buy
+34,166
New +$292K 0.02% 1019
2021
Q3
Sell
-36,670
Closed -$471K 1100
2021
Q2
$471K Buy
+36,670
New +$503K 0.16% 192
2020
Q1
Sell
-33,140
Closed -$350K 552
2019
Q4
$350K Sell
33,140
-46,712
-58% -$415K 0.1% 244
2019
Q3
$894K Buy
+79,852
New +$946K 0.33% 103
2015
Q4
Sell
-10,580
Closed -$315K 375
2015
Q3
$315K Buy
+10,580
New +$344K 0.17% 208

Other funds holding DBD

Algert Global's DBD Position: Q2 2022 in Review

Algert Global sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 34,166 shares — an estimated $230K sold.

Algert Global first reported a position in DBD in Q3 2015 and held it in 5 quarters. The position peaked at $894K in Q3 2019. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • Algert Global reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • Algert Global sold 34,166 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $230K.
  • Algert Global first reported a position in Diebold Nixdorf Incorporated in Q3 2015 and held it in 5 quarters.
  • Algert Global's Diebold Nixdorf Incorporated position peaked at $894K in Q3 2019.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on Algert Global's 13F filing for Q2 2022, filed 15 Aug 2022.